What Investors Should Do With:: Bionano Genomics, Inc., (NASDAQ: BNGO)

 

On Monday, November 16, 2020, the Company, Bionano Genomics, Inc., BNGO stock construct a change of -2.72 percent (Loss) in a total of its share price and having its trading value $0.5, which belongs to Healthcare sector and Diagnostics & Research industry. The company?s Market capitalization was $77.30M with the total Outstanding Shares of 144.65M.

 


P/S, P/E, P/B & P/C values of (NASDAQ: BNGO):

 

Bionano Genomics, Inc. institutional ownership is standing at 3.3 percent, while insider ownership is 0.07 percent. As of now, BNGO has a P/S, P/E and, P/B values of 9.2, 0, and 8.4 respectively. Its P/Cash is valued at 4.49.

 

The stock SMA50 is now at -10.39 percent. In looking, the SMA 200 we see that the stock has seen a -15.28 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 34.4 percent.


Profitability ratios:

 

Looking into the profitability ratios of BNGO stock, an investor will find its ROE, ROA, ROI standing at 0 percent, -135.7 percent and, -114.9 percent, respectively.


Beta Factor:

 

A beta factor is used to measure the volatility of the stock. The stock remaining at 8.07 percent volatile for the week and 6.5 percent for the month.


Gross / Operating Margins of BNGO:

 

It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 34.4 percent & Operating Margin seen at 0 percent.


Target Price:

 

Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Bionano Genomics, Inc. recorded it at $0.


Historical Performance In The News:

 

Taking a look at the performance of Bionano Genomics, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 1.69 percent, resulting in a performance for the month at -11.96 percent.

Therefore, the stated figure displays a quarterly performance of -29.78 percent, bringing six-month performance to 29.44 percent and year to date performance of -59.33 percent. As of now, Bionano Genomics, Inc. has a P/S, P/E and, P/B values of 9.2, 0, and 8.4 respectively. Its P/Cash is valued at 4.49.


Earnings per Share Details of Bionano Genomics, Inc.:

 

The EPS of BNGO is strolling at -1.25, measuring its EPS growth this year at -8.2 percent. As a result, the company has an EPS growth of 45.9 percent for the approaching year.